Breast Cancer Research and Treatment

A Novel Histone Deacetylase Inhibitor, Scriptaid, Enhances Expression of Functional Estrogen Receptor (ER) in ER negative human breast cancer cells in combination with 5-aza 2-deoxycytidine
pp. 177-186(10)
Authors: Keen J.C.; Yan L.; Mack K.M.; Pettit C.; Smith D.; Sharma D.; Davidson N.E.

A Feasibility Study of the Evaluation of the Florida Breast Cancer Early Detection Program Using the Statewide Cancer Registry
pp. 187-194(8)
Authors: Tamer R.; Voti L.; Fleming L.E.; MacKinnon J.; Thompson D.; Blake M.; Bean J.A.; Richardson L.C.

Tissue and Serum MUC1 Mucin Detection in Breast Cancer Patients
pp. 195-207(13)
Authors: Croce M.V.; Isla-Larrain M.T.; Demichelis S.O.; Gori J.R.; Price M.R.; Segal-Eiras A.

Ligand-Induced Regulation of ER and ER is Indicative of Human Breast Cancer Cell Proliferation
pp. 209-221(13)
Authors: Power K.A.; Thompson L.U.

A Novel Pure SERM Achieves Complete Regression of the Majority of Human Breast Cancer Tumors in Nude Mice
pp. 223-229(7)
Authors: Roy J.; Couillard S.; Gutman M.; Labrie F.

Bisphosphonate Induced Growth Inhibition of Breast Cancer Cells is Augmented by p38 Inhibition
pp. 231-241(11)
Authors: Merrell M.; Suarez-Cuervo C.; Harris K.W.; Kalervo Väänänen H.; Selander K.S.

Breast Cancer in Elderly Women: is Partial Breast Irradiation a Good Alternative?
pp. 243-251(9)
Authors: Hannoun-Levi J.M.; Courdi A.; Marsiglia H.; Namer M.; Gerard J.P.

Author Index, Volume 81
pp. 253-254(2)

Subject Index, Volume 81
pp. 255-258(6)

Instructions for Authors
pp. 259-262(4)